Expert Interviews

Savings and incentives associated with the utilization of biosimilars and unbranded biologics, including a look at how it impacts formulary access.

Inhibitor development in hemophilia can drastically impact treatment decisions but their burden can be managed.

Lifelong prophylaxis requires pharmacokinetic profiling, monitoring of factor VIII levels, and adjustments at different stages of life.

Brief rundown of patient demographics involved in REBYOTA trials and this cost-effectiveness analysis.

Sherry Rais, M.Sc., CEO and co-founder, Enthea, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, she recommends "Nickel and Dimed: On (Not) Getting By in America" by Barbara Ehrenreich to not only those in healthcare, but all readers as the book illustrates the ways in which inequality affects people’s access to healthcare.

Jason Prestinario of Particle Health is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Prestinario said sports betting is an interest of his as much of it is built from his background of high school and club college sports, being a fan of competition and even pursuing his career as a data scientist.

Renata Block, PA-C, analyzes a study on how vitiligo affects different socioeconomic groups disproportionately.

Gary M. Owens, M.D., discusses the economic costs associated with vitiligo and the impact this disease has had on the U.S. health care system in general.

Nora Lozano-Evjen of Equality Health, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Lozano-Evjen shared that after she moved to the United States from Mexico City, she became involved as a prevention specialist for two U.S. school districts, which introduced her to health and social disparities impacting underserved communities — especially those of color. The exposure to these realities pushed her toward the community health worker model she believes in today.

The role of evidence-based recommendations around biosimilars and unbranded biologics to increase patient care, plus how payers and providers evaluate biosimilars through clinical data across multiple indications.

Patients with hemophilia A face challenges with finding a lifestyle-appropriate therapy that considers self-infusion skills, management of breakthrough bleeds, and access to bleeding disorder centers.

Treatment initiation and management of comorbidities pose challenges for both pediatric and older adult patients with hemophilia A.

Overview of Markov model, a tool used for calculating potential clinical outcomes and the associated costs, and its use in the REBYOTA study. The standard of care used in the study is also defined.

Russell Graney, Founder and CEO of Aidin, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Graney talked about appreciating advice he received from healthcare veterans during the start-up of Aidin, but sifting through the right input for his business.

Kyna Fong, Ph.D., CEO and co-founder, Elation Health, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Fong shared a guilty pleasure of her's is Na Ya Dessert Cafe in San Francisco's Hayes Valley. In addition to a guilty pleasure, Fong also talked about a career turning point she experienced, and what book she recommends to healthcare professionals.

Chesahna Kindred, M.D., MBA, FAAD, and Renata Block, PA-C, review areas of the body that are typically affected, and are more problematic to manage, in patients with vitiligo. Comorbidities that put certain patients at higher risk than others are also discussed.

A panel of experts discuss the diagnosis and pathophysiology of vitiligo.

Mike Steelman, vice president, Managed Markets, Dexcom presented on the pathways to implement non-prescription digital therapeutics at the 2023 PBMI Annual National Conference in Orlando. In this interview with Managed Healthcare Executive, Steelman suggests that creating "certainty in an uncertain world" in the digital therapeutic space could potentially open up doors for further use of these tools.

At the 2023 PBMI Annual National Conference in Orlando, Ellen Feeney, director of Clinical Pharmacy Strategies at Highmark discusses how these new programs payers are using to control medication costs work, and shares how costs of the GLP-1s should be managed.

Ittai Dayan, M.D., M.P.H., co-founder and CEO of Rhino Health, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In this video interview, Dayan not only shares a good read for healthcare professionals, but also a turning point that changed his career trajectory and even a guilty pleasure of his — which involves finishing a scoop or more of his son's ice cream.

At this year's PBMI Annual National Conference in Orlando Ben Urick, principal health outcomes researcher at Prime Therapeutics, shared methods for medical cost savings through adherence improvement using integrated medical and pharmacy claims data.

A glance at the process and regulations of switching, plus how an interchangeability study is conducted.

Alina M. Czekai, M.P.H., vice president, value-based care strategy, Cohere Health, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In this video interview, Czekai shares a turning point that changed her career trajectory, recommends a good read for healthcare professionals, and even spills her guilty pleasure: some time with the "Real Housewives" and a glass of red wine.

The challenges associated with treating hemophilia A become increasingly complex with varying disease severity.

Hematologist Jonathan Roberts, MD, discusses the history and challenges of hemophilia A treatment.

Explanation of the cost-effectiveness analysis and additional factors involved when treating C. Difficile with REBYOTA.

Definitions of originator biologics, biosimilars, and unbranded biologics, including their lifespan in the marketplace.

Specialty pharmacies prioritize minimizing drug waste in hemophilia A treatment, aiming for near-complete dosing while adhering to payer limits and addressing potential drug hoarding among patients.

Specialty pharmacies can help patients with hemophilia A maintain hemostasis and ensure patient safety through medication therapy management, utilizing regional care coordinators and direct pharmacist outreach, and by maintaining consistent provider communication.